The Clinical Consequences of Stimulant Use: Focus on Intoxication, Washout, and Therapies
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
The Clinical Consequences of Stimulant Use: Focus on Intoxication, Washout, and Therapies
Recorded: Thursday, April 4, 2024 to Sunday, April 7, 2024
On-Demand Session
Overview
This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to assess (including laboratory testing and analysis) and manage stimulant toxicity and wash out syndromes related to stimulant abstinence.
This focus session will describe the neurobiological effects of stimulants and provide clinicians with tools for assessment and management of stimulant intoxication and other adverse effects from stimulants, such as physiological effects of abstinence from stimulants. We will provide information on laboratory testing for stimulants and the utility of testing. We shall also review the pharmacology and adverse effects of medications used in the treatment of stimulant use disorder including naltrexone, bupropion, modafinil, and mixed amphetamine salts.
The target audience for this Intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This session addresses the following ACGME Competencies: Patient Care and Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
This session addresses the following ICPE Competencies:Roles and Responsibilities, Teams and Teamwork
Learning Objectives
Upon completion, learners will be able to:
- Describe the neurobiological effects of various stimulant classes
- Explain how to assess (including laboratory testing and analysis) and manage stimulant toxicity and wash out syndromes related to stimulant abstinence
- Highlight the pharmacology and adverse effects of medications used in the treatment of stimulant intoxication and stimulant use disorder
Registration Rates
| Rate Description | Rate |
| ASAM Member | $29 |
| Non-Member | $39 |
| Associate Member | $19 |
| Resident Member* | $19 |
| Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 05/06/2024 - 04/06/2027
User Access Closed: 05/06/2027
Session Instructions
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
JoAn Laes
MD
JoAn Laes, MD is an addiction medicine physician and consulting medical toxicologist. Her focus is inpatient addiction medicine and toxicology consultation, and outpatient treatment of opioid and other substance use disorders. She is an owner at Twin Cities Toxicology, providing consultation, medical directorship, and expert opinion in the fields of addiction medicine and medical toxicology. She is board-certified in Internal Medicine, Addiction Medicine, and Medical Toxicology. She completed an internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota. She has spoken nationally on the subjects of addiction medicine and toxicology.
No relevant financial relationships
Timothy J. Wiegand
MD, FACMT, FAACT, DFASAM
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM, specializes in Medical Toxicology and Addiction Medicine. He is an Associate Professor of Emergency Medicine and Director of the Toxicology/Addiction Consult Service at Strong Memorial Hospital and the University of Rochester Medical Center. He is Program Director for the URMC Addiction Medicine Fellowship Program, based out of the Department of Emergency Medicine and core faculty for their Emergency Medicine residency. Dr. Wiegand is also Medical Director for Huther Doyle, an addiction services provider in Rochester, New York.
In addition to ED, hospital, and clinic work treating intoxication, withdrawal, and assisting with pain management for patients maintained on Medications for Opioid Use Disorder Dr. Wiegand is involved with education and research in toxicology and addiction and he lectures locally, nationally, and internationally. Dr. Wiegand serves on the ASAM Board of Directors as Vice President; he is President of NYSAM and he is completing a second term on the Board of the American College of Medical Toxicology.
Dr. Wiegand serves in a volunteer capacity for many local, state, and national committees. He has been awarded the Charlotte Hegedus Award from the National Council on Alcoholism and Drug Dependence for professionals who have consistently demonstrated high level of cooperative work with individuals or groups with substance use disorders for at least five years. Dr. Wiegand is the 2022 awardee of the American Society of Addiction Medicine Annual Award. This award is given to an individual for outstanding contributions to the growth and vitality of ASAM, for thoughtful leadership in the field, and for a deep understanding of the art and science of Addiction Medicine.” And “for expanding the frontiers of the field of Addiction Medicine and broadening our understanding of the addictive process, through research and innovation.” He was also awarded the 2022 ACMT Service Award.
Jeremiah D. Fairbanks
DO
Jeremiah Fairbanks, DO is a current addiction medicine fellow at the University of Minnesota. He completed his medical training at Des Moines University followed by a family medicine residency through the University of Minnesota. He has helped develop programs treating office based opioid use disorder through primary care in southern Minnesota and has his family medicine board certification.
Ian Latham, MD
Addiction Medicine Fellow
Univeristy of Minnesota
Ian Latham, MD is an Addiction Medicine Fellow at the University of Minnesota; he recently completed his residency in Family Medicine at the University of Minnesota / North Memorial residency program. He completed his undergraduate education in Molecular Biology at the University of Wisconsin – Madison and his medical education at the Lewis Katz School of Medicine at Temple University in Philadelphia, Pennsylvania where he participated in research in Narrative Medicine, trauma-informed addiction care, and mobile services for buprenorphine treatment. Ian has a particular interest in working with patients who identify within the LGBTQ+ community, the management of behavioral addictions, and the treatment and prevention of viral disease among people living with addiction.
Accreditation & Credit Designation Statements
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This activity awards 1.25 Nursing contact hours.
PAs
ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/06/2027. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Continuing Education Credits (CEUs)
Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
- American Board of Medical Specialties (ABMS)
- American Board of Preventive Medicine (ABPM)
- American Board of Internal Medicine (ABIM)
- American Board of Pediatrics (ABP)
- American Board of Surgery (ABS)
- American Board of Psychiatry and Neurology (ABPN)
- American Board of Addiction Medicine (ABAM)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
- Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Disclosure Information
In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. Click here to view the full disclosure listing.
Key:
Complete
Next
Failed
Available
Locked